Table 1.
Baseline characteristics of subjects
| Characteristic | N | |
|---|---|---|
| General | ||
| Age, years | 268 | 70.0 ± 4.5 |
| Female, n (%) | 268 | 245 (91.4) |
| Caucasian, n (%) | 268 | 268 (100) |
| BMI (kg/m2) | 251 | 26.5 ± 4.9 |
| Vital signs | ||
| Systolic blood pressure (mmHg) | 166 | 130.7 ± 16.9 |
| Diastolic blood pressure (mmHg) | 166 | 79.5 ± 8.7 |
| Heart rate (bpm) | 149 | 76.2 ± 9.1 |
| Concomitant medications | ||
| ≥ 3 medications, n (%) | 222 | 114 (51.4) |
| Had < 3 medications, n (%) | 222 | 108 (48.6) |
| Had no other medication, n (%) | 222 | 33 (14.9) |
| Vitamin D supplementation, n (%) | 222 | 132 (59.5) |
| Comorbid diseases | ||
| Total medical anomalies, n (%) | 147 | 42 (28.6) |
| Muscle/skeleton disorders, n (%) | 147 | 17 (11.6) |
| Circulatory systems disorders, n (%) | 147 | 8 (5.4) |
| Gastroesophageal reflux, n (%) | 147 | 3 (2.0) |
| Other disorders | 147 | 13 (4.1) |
Data are presented as number and % or mean and SD. N represents the number of subjects where data was available. Percentages (%) are based on the number of subjects with data
BMI body mass index